Written by
John ProgarGeorgia has the most restrictive operational medical cannabis program in the United States. The state's 5% THC cap produces products so dilute they are comparable to over-the-counter hemp items. Vaporization is banned. Flower is banned. For patients with acute PTSD, breakthrough cancer pain, or severe seizures — conditions that demand fast-acting, adequate-strength relief — Georgia's program often falls short of what medicine requires. The Marijuana Policy Project doesn't even count Georgia as a medical cannabis state.
That could change in 2026. Senate Bill 220, the "Putting Georgia's Patients First Act," would raise the THC cap tenfold — from 5% to 50% — legalize vaporization, remove "severe or end-stage" barriers from qualifying conditions, and add lupus and inflammatory bowel disease to the eligible list. The bill already passed the Georgia Senate 39–17 with strong bipartisan support. Now it's the House's turn, and the 2026 legislative session that opened January 12 gives lawmakers until April 6 to act.
Here's what the bill does, who's fighting for it, and what it means for Georgia's 33,000+ registered patients — and the estimated 600,000 who could qualify.
What SB 220 Would Change
The bill, sponsored by Sen. Matt Brass (R-Newnan), a Navy veteran and chair of the Senate Rules Committee, proposes the most significant overhaul of Georgia's medical cannabis laws since the program was created:
Would change:
- Raises the THC cap from 5% to 50% by weight — a tenfold increase
- Legalizes vaporization/inhalation of medical cannabis (raw flower and smoking remain banned)
- Renames "low THC oil" to "medical cannabis" throughout Georgia code
- Removes the "severe or end-stage" requirement for cancer, Parkinson's, multiple sclerosis, sickle cell disease, Alzheimer's, and AIDS
- Adds two new qualifying conditions: lupus and inflammatory bowel disease
- Allows caregivers to pick up medical cannabis from pharmacies on behalf of patients
- Provides reciprocity for out-of-state medical cannabis patients
- Replaces the 20-fluid-ounce possession limit with a 2-ounce limit of medical cannabis (higher concentration offsets the lower volume)
Still prohibited under SB 220: raw plant material (flower and pre-rolls), food products (cookies and candies), smoking, and hemp products from the medical market.
Georgia SB 220 Senate Vote and Floor Fight
SB 220 passed the Georgia Senate on March 6, 2025 — Crossover Day — by a vote of 39–17 after more than an hour of contentious debate. The vote was notably bipartisan: with a Senate composed of 33 Republicans and 23 Democrats, the bill required substantial support from both caucuses.
The bill had 20 sponsors — 12 Republicans and 8 Democrats. Three floor amendments aimed at weakening the bill were decisively defeated:
| Amendment | Result |
|---|---|
| Reduce the THC cap below 50% | Failed 12–43 |
| Remove the vaping/inhalation provision | Failed 13–43 |
| Remove PTSD and intractable pain from qualifying conditions | Failed 12–44 |
| Allow caregivers to pick up from pharmacies | Adopted |
The opposition was vocal but small. Sen. Ed Setzler (R-Acworth) argued the bill was "about getting people stoned" and warned of "increased adolescent exposure and long-term cognitive harms." Sen. Randy Robertson (R-Cataula), the Senate Majority Whip, called medical marijuana a "gateway drug." But only 17 senators consistently voted against the bill and its provisions.
After crossing to the House, SB 220 was referred to committee but never received a floor vote before the 2025 session ended on April 4. The bill carries over into the 2026 session, which runs through April 6, 2026.
Why Veterans Are Leading Georgia's Medical Cannabis Fight
The most politically compelling voices behind SB 220 are military veterans who describe firsthand how Georgia's 5% THC cap fails patients with acute symptoms.
Gary Herber, a U.S. Army veteran and Purple Heart recipient who served with the 10th Mountain Division in Afghanistan, suffered a brain injury and chronic pain from an explosion. After years on pharmaceutical narcotics, he turned to Georgia's medical cannabis program — and describes the 5% cap as inadequate for acute episodes.
On opioid treatment: "In a lot of ways, it ruined my life. It turned me into a person that had very little drive, very little emotion, very little feeling."
On medical cannabis: "My life has changed in such great ways. First of all, I can feel again. Just... I have emotions again. And I'm able to manage the anxiety, the pain, all the stereotypical symptoms of traumatic brain injury and neurological disease."
On why vaporization matters: "I would have panic attacks, and those panic attacks are something that, when it happens, you need immediate relief. And the medications we have now, the cannabis that we have now in Georgia, is not necessarily immediate onset."
Jason Quinn, a retired U.S. Marine Corps Major, put the THC cap in clinical terms: "It's limiting what our doctors can do for us in helping us to fight our chronic pain."
Dr. Elmore Alexander, a medical marijuana physician, explained the pharmacological gap: "My veterans that have PTSD, they need immediate onset, and the tinctures that we're using in Georgia take a while to kick in, whereas vaping is more immediate." He described watching veteran patients improve dramatically after accessing medical cannabis: "They became positive about life, they started to sleep better, their joy came back."
The science supports their argument. Oral cannabis (tinctures, capsules) has a bioavailability of roughly 10–20% with onset taking 30–90 minutes. Vaporized cannabis reaches approximately 50–60% bioavailability — nearly 4x higher — with onset within 2–10 minutes. For a veteran experiencing a panic attack or a cancer patient with acute nausea who can't hold down oral medication, that difference is the difference between relief and suffering.
The Blue Ribbon Committee and the Path Through the House
After SB 220 stalled, House Speaker Jon Burns (R-Newington) created a Blue Ribbon Study Committee on Georgia's Medical Marijuana and Hemp Policies, chaired by Rep. Mark Newton (R-Augusta), a physician. The 13-member committee held four public hearings between July and October 2025, examining medical studies, hearing testimony from physicians, patients, and industry stakeholders, and comparing Georgia's laws to other states.
The committee's recommendations for the 2026 session are expected to shape whether the full 50% THC cap survives or gets negotiated down to a lower compromise. The critical unknowns: whether Speaker Burns allows SB 220 to reach the House floor, and whether a conference committee would be needed to reconcile the Senate and House versions.
Meanwhile, a companion bill — HB 227, also titled the "Putting Georgia's Patients First Act" — passed the House 164–1 in February 2025. HB 227 renames "low-THC oil" to "medical cannabis," adds lupus, and removes the "severe/end-stage" requirements, but does not raise the THC cap or allow vaporization. The near-unanimous House vote demonstrates broad bipartisan consensus on at least modest expansion — the question is whether the House will go further.
How Georgia Compares to Other States
Georgia's 5% THC cap makes it the most restrictive operational medical cannabis program in the nation. The contrast with peer conservative and Southern states is stark:
| State | THC Limit | Flower/Vaping | Registered Patients | Annual Sales |
|---|---|---|---|---|
| Georgia | 5% (SB 220 would raise to 50%) | No flower, no vaping | ~33,000 | Not publicly reported |
| Florida | No cap on flower | Flower + vaping since 2019 | 886,200+ | ~$2.1 billion |
| Arkansas | No % cap | Flower + vaping | ~112,760 | $275.9 million |
| Mississippi | 30% flower, 60% concentrate | Flower + vaping | Growing (opened Jan 2023) | $118.7 million |
| Kentucky | 35% flower, 70% concentrate | Vaping allowed | New (sales began Jan 2025) | New market |
| Louisiana | No specific cap | Flower since 2022 | Growing | Growing |
| Texas | 10mg THC/dose | No flower, vaping pending | 135,470 | Limited |
| Alabama | N/A | No flower, no vaping | 1 (not yet selling) | $0 |
Florida's experience is especially instructive: a conservative state with a comprehensive medical cannabis program (no THC cap on flower, vaping allowed) serves 886,200+ patients — approximately 4% of its population — and generates over $2.1 billion in annual sales. Mississippi, which opened dispensaries the same year as Georgia (2023), has already reached $118.7 million in annual sales because it allows flower and has reasonable THC caps. Arkansas generates $275.9 million annually from roughly 112,000 patients.
If SB 220 passes and Georgia's program approaches even a fraction of these benchmarks, the impact would be transformative. With an estimated 600,000 Georgians potentially eligible versus ~33,000 currently enrolled, the gap between the current restrictive program and patient demand is enormous.
Georgia's Medical Cannabis Program Today
Current Qualifying Conditions (17 Total)
Georgia's qualifying conditions include cancer, ALS, seizure disorders, multiple sclerosis, Crohn's disease, mitochondrial disease, Parkinson's disease, sickle cell disease, Tourette's syndrome, autism spectrum disorder, epidermolysis bullosa, Alzheimer's disease, AIDS, peripheral neuropathy, intractable pain, PTSD, and patients in hospice care. For many conditions, the diagnosis must currently be "severe" or "end-stage" — terms that physicians have widely criticized as medically vague and overly restrictive. SB 220 would remove these barriers.
PTSD and intractable pain account for over 70–75% of registered patients, making these conditions the primary drivers of enrollment.
Patient Enrollment
| Date | Registered Patients |
|---|---|
| January 2025 | 25,038 |
| July 2025 | ~33,000+ |
| Estimated eligible population | ~600,000 |
Current enrollment represents just ~5% of the potentially eligible population — a direct consequence of the program's restrictive THC levels and limited product forms.
Dispensaries and Access Points
Georgia has 19 GMCC-licensed dispensaries plus approximately 56 independent pharmacies carrying medical cannabis products — totaling roughly 75 access points statewide for a population of 10.8 million. Georgia is the first state in the nation to allow independent pharmacies to sell medical cannabis products. Six licensed production companies operate in the state: Trulieve (6 locations), Botanical Sciences (5), Fine Fettle (3), TheraTrue (2), Treevana Remedy (1), and True Bliss (1).
Product pricing typically ranges from $40 to $70 per item. Currently legal product forms include low-THC oil, tinctures, capsules, transdermal patches, and lotions.
How to Get a Georgia Medical Cannabis Card
To access Georgia's medical cannabis program, patients must follow these steps:
- Consult a physician — a fully licensed Georgia MD or DO who certifies your qualifying condition
- Physician submits certification — the waiver form and certification go to the Georgia Department of Public Health
- Pay the $30 state fee — cards are now valid for 5 years (extended from 2 years in October 2024)
- Receive your card — shipped via UPS with signature required; processing takes up to 10 business days
- Purchase from a licensed dispensary or pharmacy — bring your card and state ID to any of Georgia's 75 access points
Get Your Georgia Medical Cannabis Card Today
If you have a qualifying condition, MMJ.com can connect you with a licensed Georgia physician to start the certification process. With 17 qualifying conditions including intractable pain, PTSD, cancer, and seizure disorders — and SB 220 poised to dramatically expand the program — there has never been a better time to secure your access.
- $30 state fee — valid for 5 years (one of the lowest costs in the nation)
- 75 access points statewide including dispensaries and pharmacies
- No age minimum for qualifying patients
Start your evaluation today and find out if you qualify under Georgia's medical cannabis program.
What to Watch: The 2026 Legislative Timeline
| Date | Event |
|---|---|
| January 12, 2026 | 2026 Georgia legislative session convenes; SB 220 eligible for House consideration |
| Early February 2026 | Advocacy groups pushing for House action; veteran lobbying intensifies |
| March 2026 | Crossover Day — deadline for bills to pass their originating chamber |
| April 6, 2026 | Sine Die — 2026 legislative session ends |
Positive signals: The strong 39–17 Senate vote, the near-unanimous 164–1 House vote on companion HB 227, the Blue Ribbon Committee's extensive study, growing patient enrollment, accelerating federal rescheduling momentum (Trump's December 2025 executive order), and organized veteran advocacy all favor the bill's prospects.
Key challenges: The House declined to act in 2025 despite having time. The 50% THC cap specifically may face more resistance — a compromise at a lower percentage (such as 10% or 30%) is possible. And Governor Kemp, while he signed the 2019 Hope Act that created the program, has not made a public statement specifically endorsing or opposing SB 220.
For Georgia's 33,000+ registered patients and the hundreds of thousands more who could qualify, the 2026 session represents the best opportunity in a decade to bring the state's medical cannabis program in line with national standards. As former Rep. Allen Peake, the original champion of Haleigh's Hope Act, put it: "Why shouldn't we allow someone to be able to benefit not just because they're dying, but because it would improve their quality of life?"
Frequently Asked Questions
What is Georgia SB 220?
SB 220, the "Putting Georgia's Patients First Act," is a bill that would raise Georgia's medical cannabis THC cap from 5% to 50%, legalize vaporization as a delivery method, remove "severe or end-stage" requirements from qualifying conditions, add lupus and inflammatory bowel disease as qualifying conditions, and allow caregiver pharmacy pickup. It passed the Georgia Senate 39–17 in March 2025 and carries over to the 2026 legislative session for House consideration. Learn more about Georgia's medical cannabis laws.
What is the current THC limit in Georgia?
Georgia's current medical cannabis products are capped at 5% THC by weight — the most restrictive limit among all states with operational medical cannabis programs. Products must also contain CBD equal to or greater than the amount of THC. SB 220 would raise this cap to 50%, bringing Georgia closer to the standards in states like Florida, Arkansas, and Mississippi.
What conditions qualify for medical cannabis in Georgia?
Georgia recognizes 17 qualifying conditions, including intractable pain, PTSD, cancer, seizure disorders, multiple sclerosis, Crohn's disease, Parkinson's disease, ALS, autism spectrum disorder, sickle cell disease, Alzheimer's, AIDS, peripheral neuropathy, Tourette's syndrome, mitochondrial disease, epidermolysis bullosa, and patients in hospice care. PTSD and intractable pain account for over 70% of registered patients.
How do I get a Georgia medical cannabis card?
You need a certification from a fully licensed Georgia physician (MD or DO) confirming a qualifying condition. The physician submits the certification to the Georgia Department of Public Health. You then pay the $30 state fee and receive your card within about 10 business days. Cards are valid for 5 years. MMJ.com can help you connect with a licensed Georgia physician.
Does Georgia allow vaping medical cannabis?
Not currently. Vaporization and all forms of inhalation are explicitly prohibited under existing Georgia law. SB 220 would legalize non-smoked pulmonary inhalation (vaporizers, inhalers, and nebulizers) while keeping raw flower and smoking banned. Advocates argue vaporization is critical for patients who need rapid onset relief — particularly veterans with acute PTSD and cancer patients with severe nausea.
How many dispensaries are in Georgia?
Georgia has approximately 75 medical cannabis access points — 19 GMCC-licensed dispensaries plus roughly 56 independent pharmacies. Georgia is the first state in the nation to allow independent pharmacies to sell medical cannabis. Locations are spread across major cities including Atlanta, Macon, Marietta, Augusta, Columbus, Athens, Savannah area (Pooler), and others.
This article was last updated February 6, 2026. MMJ.com will continue to update this page as SB 220 progresses through the Georgia House and as the 2026 legislative session unfolds.
Georgia Medical Cannabis Sources and References
Legislation & Official Records:
- Georgia Legislature — SB 220 Bill Text — Full bill text, vote history, and amendments
- LegiScan — SB 220 Tracking — Bill status updates and legislative timeline
- BillTrack50 — SB 220 Detail — Sponsor list, co-sponsor details, and bill analysis
- Georgia Access to Medical Cannabis Commission (GMCC) — Commission history, licensing, and annual reports
- GMCC License Registry — Dispensary and production company verification
- GMCC Annual Reports — Program data and legislative reports
- Georgia Department of Public Health — Low THC Oil Registry — Patient registration, qualifying conditions, card details
News Coverage — Senate Passage & Legislative Debate: 8. Georgia Recorder — "Georgia Senators OK Bills to Limit THC Content, Expand Medical Cannabis" — Senate floor vote and amendment results 9. Marijuana Moment — "Georgia Senate Passes Bills to Expand Medical Marijuana Access" — Senate passage analysis 10. Capitol Beat — "Marijuana Inspires Debate in Georgia Senate" — Opposition arguments, Sen. Setzler and Sen. Robertson quotes
News Coverage — 2026 Session & Advocacy: 11. CBS Atlanta — "Georgia Advocates Hoping for Expansion of Medical Marijuana During 2026 Session" — Gary Herber and Dr. Elmore Alexander interviews 12. WSB-TV — "Veterans, Retired Military Call for Changes to Georgia THC Limit" — Jason Quinn, Gary Herber, and Judson Hill quotes 13. Fox 5 Atlanta — "Major Medical Marijuana Expansion Set for Debate Next Georgia Legislative Session" — 2026 session preview 14. WCTV — "GA Advocates Push Medical Marijuana Expansion" — Omari Anderson quotes, session opening coverage 15. 13WMAZ — "Musella Rep Proposes Bill to Grow Medical Cannabis Access" — Rep. Dickey and Janea Peloquin quotes 16. MJBizDaily — "Georgia Under Pressure to Expand Low-THC Medical Cannabis in 2026" — Patient enrollment data, legislative outlook
Blue Ribbon Committee Coverage: 17. Georgia Recorder — "Georgia Lawmakers Dig Into Medical Cannabis, Hemp Laws" — Committee hearings, Rep. Mark Newton quotes 18. The Marijuana Herald — "Georgia Lawmakers Conclude Hearings on Bill to Expand Medical Marijuana" — Final hearing summary 19. AllOnGeorgia — "House Blue Ribbon Study Committee Meeting Dates" — Hearing schedule and locations 20. Atlanta News First — "Georgia Lawmakers Reevaluate Medical Cannabis, Hemp Regulations" — Committee testimony and opposition arguments
Legislative History & Program Background: 21. Georgia Recorder — "Decade After Georgia Lawmakers Legalized Low-THC Medical Cannabis" — Program history, Former Rep. Allen Peake and Yolanda Bennett quotes 22. Marijuana Policy Project — Georgia — Program classification, qualifying conditions, policy analysis 23. GeorgiaStateCannabis.org — Qualifying conditions, laws, and program data 24. National Law Review / Budding Trends — "Georgia Legislature Considering Substantial Overhaul" — Legal analysis of SB 220 provisions 25. Cannabis Business Times — Georgia Coverage — Patient enrollment, licensing updates
State Comparisons & National Data: 26. NCSL — State Medical Cannabis Laws — Interstate comparison data 27. Talk Business & Politics — "Arkansas Medical Marijuana Pounds Sold in 2024" — Arkansas revenue data 28. Alabama Reflector — "Alabama Medical Cannabis Commission Approves Dispensary Licenses" — Alabama program status 29. PBS NewsHour — "Georgia Will Be 1st State to Allow Pharmacies to Sell Medical Marijuana" — Pharmacy dispensing model
Medical Research: 30. ScienceDirect — Cannabis Bioavailability and Delivery Methods — Oral vs. vaporized pharmacokinetics 31. PMC — Medical Cannabis Dosing and Administration — Clinical dosing research 32. WALB — "Businesses Could Flourish After Trump's Executive Order" — Federal rescheduling impact on Georgia
About the Author
This article was written by the MMJ.com Medical Team, a group of licensed healthcare professionals specializing in medical cannabis certification. Our team has helped over 10,000 patients obtain their medical marijuana cards.